Company
Tectonic Therapeutic
Transforming the discovery of novel GPCR-targeted therapies
- Status
- Operatingas of 2026-09-18
- Business model
- B2B
- Headquarters
- Watertown, MA, United States
- Legal name
- Tectonic Therapeutic
Claim, correct or request removal
Record updated 28 September 2026
About
Tectonic is a clinical stage biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of G-Protein Coupled Receptors (GPCRs).
Funding snapshot
- Total raised
- $333MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $185M2025-02-05
Funding rounds
- Round, 2025
- $185M2025-02-05, SEC form D sold, 29 investors
- Round, 2021
- $80.1M2021-03-31, SEC form D sold, 23 investors
- Round, 2018
- $60.5M2018-01-19, SEC form D sold, 15 investors
- Round, 2016
- $7.5M2016-07-21, SEC form D sold, 3 investors
Loading relationship preview